Precigen Financial Statements From 2010 to 2024
| I5X Stock | EUR 0.85 0.07 8.97% |
Check Precigen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Precigen's main balance sheet or income statement drivers, such as , as well as many indicators such as . Precigen financial statements analysis is a perfect complement when working with Precigen Valuation or Volatility modules.
Precigen |
Precigen Company Profit Margin Analysis
Precigen's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Precigen Profit Margin | 0.21 % |
Most of Precigen's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Precigen is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Precigen has a Profit Margin of 0.215%. This is 101.92% lower than that of the Healthcare sector and 100.93% lower than that of the Biotechnology industry. The profit margin for all Germany stocks is 116.93% lower than that of the firm.
Precigen Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Precigen's current stock value. Our valuation model uses many indicators to compare Precigen value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Precigen competition to find correlations between indicators driving Precigen's intrinsic value. More Info.Precigen is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Precigen's earnings, one of the primary drivers of an investment's value.About Precigen Financial Statements
Precigen stakeholders use historical fundamental indicators, such as Precigen's revenue or net income, to determine how well the company is positioned to perform in the future. Although Precigen investors may analyze each financial statement separately, they are all interrelated. For example, changes in Precigen's assets and liabilities are reflected in the revenues and expenses on Precigen's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Precigen. Please read more on our technical analysis and fundamental analysis pages.
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. Precigen, Inc. was founded in 1998 and is based in Germantown, Maryland. PRECIGEN INC operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 423 people.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Precigen Stock
When determining whether Precigen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Precigen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Precigen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Precigen Stock:Check out the analysis of Precigen Correlation against competitors. For more detail on how to invest in Precigen Stock please use our How to Invest in Precigen guide.You can also try the Stocks Directory module to find actively traded stocks across global markets.